Internal Medicine
RSSArticles
-
Migraine: Differences Between Males and Females
Hormonal and genetic differences factor into a greater prevalence and disability burden of migraine in teenaged girls and women; however, migraine is underdiagnosed and inadequately treated in boys and men.
-
Troponin Highly Prognostic in Decompensated Heart Failure With Preserved Ejection Fraction
Among patients with acute decompensated heart failure and preserved ejection fraction, elevated troponin is associated with worse in-hospital outcomes and long-term survival, independent of other predictors.
-
Is Exposure to Arterial Hyperoxia During Critical Illness Dangerous?
Exposure to severe hyperoxia during critical illness is associated positively with increased ICU and hospital mortality and associated negatively with ventilator-free days.
-
Risk Factors for Hospital Readmissions Ending in Death or Transition to Hospice
This study highlights factors that are associated with an increased risk of hospital readmission within 30 days and adds to the growing body of literature on healthcare use after a hospitalization for sepsis.
-
Healthcare Use in Survivors of Sepsis
The need to understand patterns of healthcare use in sepsis survivors has gained momentum to assess whether readmissions could be prevented.
-
Ventricular Tachycardia, Supraventricular Tachycardia With Right Bundle Branch Block, or Something Else?
-
Clinical Briefs
In this section: recognizing signs of binge eating disorder; a closer look an antisocial behavioral problems; and treating sickle cell pain.
-
Desmopressin Acetate Nasal Spray (Noctiva)
Desmopressin nasal spray is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least twice per night to void.
-
Polyneuropathy in the Metabolic Syndrome
The metabolic syndrome, independent of the diagnosis of diabetes, is associated with the development of polyneuropathy.
-
Pioglitazone Improves Fibrosis Scores in Nonalcoholic Steatohepatitis Patients With and Without Diabetes
In a meta-analysis of eight studies (five pioglitazone, three rosiglitazone) involving 516 patients with biopsy-proven nonalcoholic steatohepatitis, pioglitazone was found to improve fibrosis between six and 24 months.